CD4 and melanoma: In a different study, we previously found that vaccination with 12MP plus six melanoma‐specific helper peptides (6MHP) designed to stimulate both CD8+ and CD4+ T cells was associated with improved long‐term survival in males, but not in females, when compared to vaccination with 12MP plus the tetanus toxoid peptide.4